Maria Carmona-Iragui
Cited by
Cited by
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ...
Neurology 85 (7), 626-633, 2015
Relationship between β-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease
D Alcolea, M Carmona-Iragui, M Suárez-Calvet, MB Sánchez-Saudinós, ...
Journal of Alzheimer's Disease 42 (1), 157-167, 2014
Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease
J Fortea, E Vilaplana, D Alcolea, M Carmona‐Iragui, ...
Annals of neurology 76 (2), 223-230, 2014
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
ED Hamlett, EJ Goetzl, A Ledreux, V Vasilevko, HA Boger, A LaRosa, ...
Alzheimer's & Dementia 13 (5), 541-549, 2017
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ...
The Lancet Neurology 17 (10), 860-869, 2018
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
D Alcolea, E Vilaplana, J Pegueroles, V Montal, P Sánchez-Juan, ...
Neurobiology of aging 36 (6), 2018-2023, 2015
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls
F Sampedro, E Vilaplana, MJ De Leon, D Alcolea, J Pegueroles, V Montal, ...
Oncotarget 6 (29), 26663, 2015
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain
D Alcolea, P Martínez-Lage, A Izagirre, M Clerigué, M Carmona-Iragui, ...
Journal of Alzheimer's Disease 39 (4), 719-726, 2014
Cortical microstructural changes along the Alzheimer's disease continuum
V Montal, E Vilaplana, D Alcolea, J Pegueroles, O Pasternak, ...
Alzheimer's & Dementia 14 (3), 340-351, 2018
Longitudinal brain structural changes in preclinical Alzheimer's disease
J Pegueroles, E Vilaplana, V Montal, F Sampedro, D Alcolea, ...
Alzheimer's & Dementia 13 (5), 499-509, 2017
Progranulin protein levels in cerebrospinal fluid in primary neurodegenerative dementias
E Morenas-Rodríguez, L Cervera-Carles, E Vilaplana, D Alcolea, ...
Journal of Alzheimer's Disease 50 (2), 539-546, 2016
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal‐dominant Alzheimer's disease
M Carmona‐Iragui, M Balasa, B Benejam, D Alcolea, S Fernández, ...
Alzheimer's & Dementia 13 (11), 1251-1260, 2017
Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome
AR Kamer, JO Fortea, S Videla, A Mayoral, M Janal, M Carmona-Iragui, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2, 49-57, 2016
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami
E Martínez-Lizana, M Carmona-Iragui, D Alcolea, M Gómez-Choco, ...
Journal of Cerebral Blood Flow & Metabolism 35 (5), 710-717, 2015
Challenges associated with biomarker-based classification systems for Alzheimer's disease
I Illán-Gala, J Pegueroles, V Montal, E Vilaplana, M Carmona-Iragui, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 10, 346-357, 2018
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
RK Powers, R Culp-Hill, MP Ludwig, KP Smith, KA Waugh, R Minter, ...
Nature communications 10 (1), 1-11, 2019
Prevalence of sleep disorders in adults with Down syndrome: a comparative study of self-reported, actigraphic, and polysomnographic findings
S Giménez, L Videla, S Romero, B Benejam, S Clos, S Fernández, ...
Journal of Clinical Sleep Medicine 14 (10), 1725-1733, 2018
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study
J Pegueroles, A Jiménez, E Vilaplana, V Montal, M Carmona-Iragui, ...
Oncotarget 9 (78), 34691, 2018
Diagnostic and prognostic value of the combination of two measures of verbal memory in mild cognitive impairment due to Alzheimer’s disease
I Sala, I Illán-Gala, D Alcolea, MB Sánchez-Saudinós, SA Salgado, ...
Journal of Alzheimer's Disease 58 (3), 909-918, 2017
Cerebrospinal fluid anti-amyloid-β autoantibodies and amyloid PET in cerebral amyloid angiopathy-related inflammation
M Carmona-Iragui, A Fernández-Arcos, D Alcolea, F Piazza, ...
Journal of Alzheimer's Disease 50 (1), 1-7, 2016
The system can't perform the operation now. Try again later.
Articles 1–20